Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report |
Kim, Do-Sup
(Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry)
Kim, Jung-Ho (Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry) Ohe, Joo-Young (Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry) Lee, Jung-Woo (Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry) Choi, Byung-Jun (Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry) Lee, Baek-Soo (Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry) Kwon, Yong-Dae (Department of Oral and Maxillofacial Surgery, Kyung Hee University School of Dentistry) |
1 | Park YD, Kim YR, Kim DY, Chung YS, Lee JK, Kim YG, et al. Awareness of Korean dentists on bisphosphonate related osteonecrosis of the jaws: preliminary report. J Korean Assoc Oral Maxillofac Surg 2009;35:153-7. |
2 | Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw: 2014 update. J Oral Maxillofac Surg 2014;72:1938-56. DOI |
3 | Ikebe T. Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw. Oral Science International 2013;10:1-8. DOI |
4 | Ohe JY, Kwon YD, Kim YG, Lee BS, Yoon BW, Choi BJ. Features of histopathologic and radiographic findings in bisphosphonaterelated osteonecrosis of jaw: clinical review. J Korean Assoc Oral Maxillofac Surg 2008;34:550-4. |
5 | Assaf AT, Smeets R, Riecke B, Weise E, Gröbe A, Blessmann M, et al. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies. Anticancer Res 2013;33:3917-24. |
6 | Tsao C, Darby I, Ebeling PR, Walsh K, O'Brien-Simpson N, Reynolds E, et al. Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg 2013;71:1360-6. DOI |
7 | Gielen E, Vanderschueren D, Callewaert F, Boonen S. Osteoporosis in men. Best Pract Res Clin Endocrinol Metab 2011;25:321-35. DOI |
8 | Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W, et al. Treatment of osteoporosis in men. Bone 2013;53:134-44. DOI |
9 | Maurer P, Sandulescu T, Kriwalsky MS, Rashad A, Hollstein S, Stricker I, et al. Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris. Int J Oral Maxillofac Surg 2011;40:285-91. DOI |
10 | Choi BJ, Kwon YD, Lee BS, Walter C, Nawas BA. Maxillary sinusitis as a complication of oral bisphosphonate related osteonecrosis of the jaw: a case report. J Korean Oral Maxillofac Surg 2009;35:39-40. |
11 | Khan AM, Sindwani R. Bisphosphonate-related osteonecrosis of the skull base. Laryngoscope 2009;119:449-52. DOI |
12 | Rotaru H, Kim MK, Kim SG, Park YW. Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medicationrelated osteonecrosis of the jaw. J Oral Maxillofac Surg 2015;73:437-42. DOI |
13 | Farre-Guasch E, Marti-Page C, Hernadez-Alfaro F, Klein-Nulend J, Casals N. Buccal fat pad, an oral access source of human adipose stem cells with potential for osteochondral tissue engineering: an in vitro study. Tissue Eng Part C Methods 2010;16:1083-94. |